565 related articles for article (PubMed ID: 24085634)
21. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
Vijan S; Hwang EW; Hofer TP; Hayward RA
Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
[TBL] [Abstract][Full Text] [Related]
22. The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia.
Rozen P; Ron E; Fireman Z; Hallak A; Grossman A; Baratz M; Rattan J; Gilat T
Cancer; 1987 Nov; 60(10):2553-8. PubMed ID: 3664435
[TBL] [Abstract][Full Text] [Related]
23. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
[TBL] [Abstract][Full Text] [Related]
24. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis.
Vart G; Banzi R; Minozzi S
Prev Med; 2012 Aug; 55(2):87-92. PubMed ID: 22634386
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
[TBL] [Abstract][Full Text] [Related]
26. Estimated Lifetime Gained With Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials.
Bretthauer M; Wieszczy P; Løberg M; Kaminski MF; Werner TF; Helsingen LM; Mori Y; Holme Ø; Adami HO; Kalager M
JAMA Intern Med; 2023 Nov; 183(11):1196-1203. PubMed ID: 37639247
[TBL] [Abstract][Full Text] [Related]
27. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.
van Rossum LG; van Rijn AF; Verbeek AL; van Oijen MG; Laheij RJ; Fockens P; Jansen JB; Adang EM; Dekker E
Int J Cancer; 2011 Apr; 128(8):1908-17. PubMed ID: 20589677
[TBL] [Abstract][Full Text] [Related]
30. Screening of patients after surgery for colorectal carcinoma: value of faecal occult blood testing and flexible sigmoidoscopy.
Chapuis PH; Goulston KJ; Pheils MT
Med J Aust; 1980 May; 1(11):538-40. PubMed ID: 7393036
[TBL] [Abstract][Full Text] [Related]
31. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
33. Evidence for colorectal cancer screening.
Bretthauer M
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
[TBL] [Abstract][Full Text] [Related]
34. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
35. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
[TBL] [Abstract][Full Text] [Related]
37. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
O'Leary BA; Olynyk JK; Neville AM; Platell CF
J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
